Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Go back to Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300| (NYSE: BHVN) | Delayed: 14.96 +0.18 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.78 | 52 Week High | $ | |||
| Open | $14.78 | 52 Week Low | $ | |||
| Day High | $15.23 | P/E | N/A | |||
| Day Low | $14.50 | EPS | $ | |||
| Volume | 2,258,165 | |||||
